Anuh-Pharma Stock/Share Prices, Buy and Sell Anuh-Pharma BSE Stocks

Market Snapshot

BSE Sensex: 40707.31 0.40%
BSE 500: 15499.84 0.24%
BSE 200: 5008.68 0.25%
BSE 100: 11984.08 0.24%
BSE Mid-Cap: 14808.54 0.23%
BSE Small-Cap: 14900.68 0.03%
BANKEX: 27969.34 1.36%
BSE IT Sector: 21943.79 -0.44%
Nifty 50: 11937.65 0.34%
Nifty 500: 9756.6 0.24%
Nifty 200: 6135.85 0.27%
Nifty 100: 12009 0.27%
Nifty Midcap 100: 17065.45 0.25%
Nifty Small 100: 5897.7 -0.11%
Nifty IT: 21577.65 -0.54%
Nifty PSU Bank: 1314.15 0.73%

News:

GMM Pfaudler Q2 PAT up 29% YoY...
Ultratech Cement gains on stel...
Dilip Buildcon climbs on emerg...
Amber Enterprises India Ltd le...
Colgate Palmolive Q2 PAT rises...

Anuh Pharma Ltd BSE
Pharmaceuticals, Small Cap

Invest

21 Oct 2020 | 03:59 PM

162.10

-5.20 (-3.11%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

132.3%

Return (1Y)

Beaten S&P BSE Sensex by 127.83%
More Volatile

4.33%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 2.33%
Consistent Performer

9/12

Months

beaten S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

219

News & Announcements

Anuh Pharma hits the roof after approval for malaria drug
22 days ago

Anuh Pharma hits the roof after approval for malaria drug

29 - Sep - 2020 12:00 AM | 22 days ago

Shares of Anuh Pharma rose for third consecutive day. The stock has surged 13.34% in three days from its previous closing low of Rs 183.35 hit on 24 September 2020.
The scrip is up nearly 327% from its 52-week low of Rs 48.70 posted on 24 March 2020. The stock hit a 52-week high of Rs 218.7 on 25 August 2020.
Anuh Pharma in a regulatory filing after market hours on Monday announced that it has received approval from WHO - Geneva for prequalification for Pyrimethamine API which is used as anti -malarial drugs.
Anuh Pharma manufactures active pharmaceutical ingredients (APIs).
Powered by Capital Market - Live News
Anuh Pharma receives approval from WHO Geneva Prequalification for Pyrimcthamine API
23 days ago

Anuh Pharma receives approval from WHO Geneva Prequalification for Pyrimcthamine API

28 - Sep - 2020 12:00 AM | 23 days ago

Anuh Pharma has received approval from WHO Geneva Prequalification for Pyrimcthamine API which is used as anti - malarial durgs.
Powered by Capital Market - Live News
Board of Anuh Pharma allots 2.50 crore equity shares under bonus issue
29 days ago

Board of Anuh Pharma allots 2.50 crore equity shares under bonus issue

22 - Sep - 2020 12:00 AM | 29 days ago

The Board of Anuh Pharma vide circulation resolution dated 22 September 2020 has approved the allotment of 2,50,56,000 Equity Shares each aggregating Rs. 12,52,80,000/- issued by capitalization of reserves and distributed as fully paid-up Bonus Shares in the ratio of 1: 1 i.e. 1 (One) equity shares for every 1 (One) equity share held to those shareholders whose names appear on the Register of Members / Register of Beneficiaries as at the closing of 21 September 2020 (RecordDate).
Powered by Capital Market - Live News
Anuh Pharma schedules AGM
74 days ago

Anuh Pharma schedules AGM

08 - Aug - 2020 12:00 AM | 74 days ago

Anuh Pharma announced that the 60th Annual General Meeting (AGM) of the company will be held on 11 September 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Anuh Pharma Ltd has given the 3rd best dividend yield 1.37 for 3 Year among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Anuh Pharma Ltd BSE Pharmaceuticals, Small Cap

162.10 -5.20 (-3.11%)

News & Announcements

Price vs Volume

Stock Trivia

Anuh Pharma Ltd BSE
Pharmaceuticals, Small Cap

162.10

-5.20 (-3.11%)